← back to search

Elias Mouchlianitis

University of East London · GB
Area of research
Cognitive Neuroscience · Psychiatry and Mental health
Research interest
Research interests include Functional Brain Connectivity Studies, Schizophrenia research and treatment, Advanced MRI Techniques and Applications, and Neural and Behavioral Psychology Studies.
h-index
24
citations
1,809
works
67
NIH funding
primary concept
email

Recent publications

Variability and magnitude of brain glutamate levels in schizophrenia: a meta and mega-analysis
Molecular Psychiatry 2023cited by 73position: middledoi
Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level
JAMA Psychiatry 2021cited by 144position: middledoi
Cognitive control network connectivity differentially disrupted in treatment resistant schizophrenia
NeuroImage Clinical 2021cited by 34position: middledoi
Interactive effects of task load and music tempo on psychological, psychophysiological, and behavioural outcomes during simulated driving
Ergonomics 2021cited by 32position: middledoi
A Novel Virtual Reality Assessment of Functional Cognition: Validation Study
Journal of Medical Internet Research 2021cited by 31position: middledoi
Neural correlates of positive and negative symptoms through the illness course: an fMRI study in early psychosis and chronic schizophrenia
Scientific Reports 2019cited by 60position: middledoi
Mapping cortical surface features in treatment resistant schizophrenia with in vivo structural MRI
Psychiatry Research 2019cited by 29position: middledoi
Differential neural reward mechanisms in treatment-responsive and treatment-resistant schizophrenia
Psychological Medicine 2018cited by 41position: middledoi
Examination of the Neural Basis of Psychoticlike Experiences in Adolescence During Reward Processing
JAMA Psychiatry 2018cited by 36position: middledoi
Brain-imaging studies of treatment-resistant schizophrenia: a systematic review
The Lancet Psychiatry 2016cited by 140position: firstdoi
Treatment-Resistant Schizophrenia Patients Show Elevated Anterior Cingulate Cortex Glutamate Compared to Treatment-Responsive
Schizophrenia Bulletin 2015cited by 226position: firstdoi
Dopamine Function in Cigarette Smokers: An [18F]-DOPA PET Study
Neuropsychopharmacology 2014cited by 47position: middledoi
Measuring endogenous changes in serotonergic neurotransmission in humans: a [11C]CUMI-101 PET challenge study
Molecular Psychiatry 2012cited by 67position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Sukhwinder S. Shergill · Medway School of Pharmacy5 papers (2018–2021)Lucy Vanes · Wellcome Centre for Human Neuroimaging4 papers (2018–2021)Oliver Howes · King's College London4 papers (2012–2016)Federico Turkheimer · King's College London3 papers (2012–2015)Sudhakar Selvaraj · The University of Texas Health Science Center3 papers (2012–2015)Michael Bloomfield · Austin College2 papers (2014–2015)Alice Egerton · King's College London2 papers (2014–2015)Krisna Patel · University of Leeds2 papers (2019–2019)Bruno B. Averbeck · Eunice Kennedy Shriver National Institute of Child Health and Human Development2 papers (2018–2021)Timea Szentgyorgyi · King's College London2 papers (2019–2021)Erica F. Barry · Cornell University2 papers (2019–2019)Charlotte Mary Horne · King's College London2 papers (2019–2021) · 1 papers (2021–2021)Tracy Collier · King's College London1 papers (2018–2018)Vincent Law · University of London1 papers (2015–2015)James Stone · Brighton and Sussex Medical School1 papers (2015–2015)Dan W. Joyce · King's College London1 papers (2019–2019)Costas I. Karageorghis · University of London1 papers (2021–2021)Adam Waldman · Imperial College Healthcare NHS Trust1 papers (2015–2015)Katherine Beck · King's College London1 papers (2015–2015)